Webcast presentations from the 9th Annual ALS TDI Leadership Summit held on Thursday, October 3, 2013
Amyotrophic Lateral Sclerosis: Progress Towards Effective Treatments,
Steve Perrin, Ph.D.
Affiliation(s): CEO & Chief Scientific Officer, ALS TDI (USA)
High-throughput screens to define novel mechanisms of ALS,
Aaron Gitler, Ph.D.
Affiliation(s): Associate Professor, Genetics, Stanford School of Medicine
Using Human Induced Pluripotent Stem cells as Target and Drug Discovery Tools for ALS,
Steve Finkbeiner, M.D., Ph.D.
Affiliation(s): Associate Director & Senior Investigator, Gladstone Institutes, UCSF